Lasergen is a biotechnology company developing and commercializing technologies for genomic applications.
LaserGen, Inc., a biotechnology company, engages in the development and commercialization of technologies for genomics application. It develops various technologies for sequencing applications. The company's products detect heritable and somatic sequence variations in the human genome for use as diagnostics tools for the management of diseases. LaserGen, Inc. was incorporated in 2002 and is based in Houston, Texas.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 7, 2016 | Series B | $80M | 1 | Agilent Technologies | — | Detail |
Aug 30, 2011 | Series A | $5M | 2 | Aspen MedTech | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Agilent Technologies | Yes | Series B |
Aspen MedTech | Yes | Series A |
LBS Technologies | — | Series A |